INVELTYS Drug Patent Profile
✉ Email this page to a colleague
When do Inveltys patents expire, and what generic alternatives are available?
Inveltys is a drug marketed by Alcon Labs Inc and is included in one NDA. There are eleven patents protecting this drug.
This drug has eighty-two patent family members in twelve countries.
The generic ingredient in INVELTYS is loteprednol etabonate. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Inveltys
A generic version of INVELTYS was approved as loteprednol etabonate by SENTISS on April 17th, 2019.
Summary for INVELTYS
International Patents: | 82 |
US Patents: | 11 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Patent Applications: | 4,910 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for INVELTYS |
What excipients (inactive ingredients) are in INVELTYS? | INVELTYS excipients list |
DailyMed Link: | INVELTYS at DailyMed |


Pharmacology for INVELTYS
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for INVELTYS
US Patents and Regulatory Information for INVELTYS
INVELTYS is protected by twelve US patents.
Patents protecting INVELTYS
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR DELIVERING A PHARMACEUTICAL AGENT ACROSS A MUCOSAL BARRIER
Compositions and methods for ophthalmic and/or other applications
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions and methods for ophthalmic and/or other applications
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions and methods for ophthalmic and/or other applications
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR TREATING OCULAR INFLAMMATION
Compositions and methods for ophthalmic and/or other applications
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF REDUCING POST-SURGICAL PAIN FOLLOWING OCULAR SURGERY
Compositions and methods for ophthalmic and/or other applications
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD OF TREATING POSTOPERATIVE INFLAMMATION FOLLOWING OCULAR SURGERY
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR DELIVERING A COMPOSITION TO A MUCUS MEMBRANE
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR DELIVERING A COMPOSITION TO A MUCUS MEMBRANE
Nanocrystals, compositions, and methods that aid particle transport in mucus
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR DELIVERING A PHARMACEUTICAL AGENT ACROSS A MUCOSAL BARRIER
Compositions and methods for ophthalmic and/or other applications
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR TREATING INFLAMMATION AND/OR OTHER DISORDERS IN AN EYE OF A PATIENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for INVELTYS
See the table below for patents covering INVELTYS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2016535777 | 眼科及び/又はその他の応用のための組成物及び方法 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2013166436 | ⤷ Try a Trial | |
Chile | 2014002956 | Composicion farmaceutica ocular que comprende particulas recubiertas de dimension menor a 1 micron, con un nucleo que comprende etaboato de loteprednol y un recubrimiento con modificadores de superficie; y uso para tratar la inflamacion, degeneracion macular, edema macular u otro trastorno del ojo. | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |